关节镜下上关节囊重建联合阔筋膜自体移植与LARS韧带或聚丙烯补片合成支架增强:治疗不可修复性肩袖撕裂至少2年随访的技术比较
回顾性比较92例不可修复性肩袖撕裂患者接受关节镜下上关节囊重建(ASCR)联合阔筋膜自体移植并分别用LARS韧带(PET)或聚丙烯补片增强的临床结局,82例完成随访。LARS组在ASES评分、UCLA评分、Constant-Murley评分、主动前屈上举及移植愈合率上均显著优于补片组。作者认为LARS韧带支架增强的自体阔筋膜ASCR功能结局和移植愈合率更优。
要点
- LARS组ASES评分92.6±8.0 vs 补片组77.8±21.3,P<.001。
- LARS组移植愈合率91% vs 补片组72%,P=.027。
- LARS组主动前屈上举161.4±19.7 vs 补片组124.2±31.3,P<.001。
核心结论
- 与ASCR联合聚丙烯补片支架增强相比,自体阔筋膜ASCR联合LARS韧带支架增强获得了更好的功能结局和移植愈合率。
研究设计与样本
- 病例系列,证据等级4级;回顾性评估2016年至2022年间接受ASCR的92例不可修复性肩袖撕裂患者,其中82例符合纳入和排除标准并完成随访。
- LARS韧带(PET材料;Corin Group)增强阔筋膜自体移植用于43例患者(LARS组),聚丙烯补片增强阔筋膜自体移植用于39例患者(补片组)。
- 临床结局于术前和末次随访时采用疼痛视觉模拟评分、关节活动度、美国肩肘外科医师(ASES)评分、加州大学洛杉矶分校(UCLA)评分和Constant-Murley评分(CMS)评估;影像学结局根据肩袖关节病和肩峰肱骨距离分期评估;移植完整性和肌肉脂肪浸润通过磁共振成像评估。
主要发现
- 两组末次随访时临床和影像学结局均较术前显著改善。
- LARS组平均ASES评分(92.6±8.0 vs 77.8±21.3;P<.001)、UCLA评分(31.5±3.9 vs 24.4±7.5;P<.001)和CMS(86.6±7.2 vs 67.9±18.9;P<.001)均显著优于补片组。
- LARS组平均主动前屈上举(161.4±19.7)显著高于补片组(124.2±31.3)(P<.001)。
- LARS组移植愈合率(91%)显著高于补片组(72%)(P=.027),末次随访时LARS组肩峰肱骨距离(7.0±1.5 mm)显著大于补片组(6.3±1.5 mm)(P=.036)。
- 亚组分析显示,移植完整的患者在功能结局和主动前屈上举方面改善更显著。
关键数值与推荐
- LARS组ASES评分92.6±8.0 vs 补片组77.8±21.3(P<.001),LARS组更高。
- LARS组UCLA评分31.5±3.9 vs 补片组24.4±7.5(P<.001),LARS组更高。
- LARS组CMS 86.6±7.2 vs 补片组67.9±18.9(P<.001),LARS组更高。
- LARS组主动前屈上举161.4±19.7 vs 补片组124.2±31.3(P<.001),LARS组更高。
- LARS组移植愈合率91% vs 补片组72%(P=.027),LARS组更高;LARS组肩峰肱骨距离7.0±1.5 mm vs 补片组6.3±1.5 mm(P=.036),LARS组更大。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arthroscopic superior capsule reconstruction (ASCR) with combined fascia lata autograft and synthetic scaffold patch graft has been reported to improve graft healing and treat irreparable rotator cuff tears (RCTs). Information about the surgical outcomes of using different synthetic scaffold materials is limited. PURPOSE: To compare the clinical outcomes of the ASCR technique using LARS ligament with polyethylene terephthalate (PET) material versus polypropylene (PP) mesh scaffold augmentation to treat irreparable RCTs. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: The data of 92 patients with irreparable RCTs who underwent ASCR between 2016 and 2022 were retrospectively evaluated. Among them, 82 of 92 patients who met the inclusion and exclusion criteria were available for follow-up. Fascia lata autografts augmented with LARS ligament (LARS with PET; Corin Group) were used in 43 patients (LARS group), and fascia lata autografts with PP mesh augmentation were used in 39 patients (mesh group). Clinical outcomes were evaluated preoperatively and at a final follow-up by a visual analog scale for pain score and range of motion along with the American Shoulder and Elbow Surgeons (ASES) score, University of California, Los Angeles (UCLA) score, and Constant-Murley score (CMS). Radiological outcomes were assessed according to the rotator cuff arthropathy and acromiohumeral distance stages. Graft integrity and muscle fatty infiltration were evaluated by magnetic resonance imaging. RESULTS: Both groups showed significant improvement in clinical and radiological outcomes at the final follow-up. The LARS group showed significantly better outcomes in mean ASES score (92.6 ± 8.0 vs 77.8 ± 21.3; P < .001), UCLA score (31.5 ± 3.9 vs 24.4 ± 7.5; P < .001), and CMS (86.6 ± 7.2 vs 67.9 ± 18.9; P < .001) compared with the mesh group. The mean active elevation was significantly higher in the LARS group (161.4 ± 19.7) than in the mesh group (124.2 ± 31.3) (P < .001). The graft healing rate was also significantly higher in the LARS group (91%) than in the mesh group (72%) (P = .027), and acromiohumeral distance was significantly greater in the LARS group (7.0 ± 1.5 mm) than in the mesh group (6.3 ± 1.5 mm) at the final follow-up (P = .036). Subgroup analysis revealed that patients with intact grafts demonstrated a more substantial improvement in functional outcomes and active elevation. CONCLUSION: Compared with combining ASCR with a synthetic PP mesh scaffold graft, augmenting autogenous fascia lata ASCR with a synthetic LARS ligament scaffold graft achieved better functional outcomes and graft healing rate.
引用
- Bi M, Sun Z, Wei L, et al. Arthroscopic Superior Capsule Reconstruction With Combined Fascia Lata Autograft Augmented With Either LARS Ligament or Polypropylene Mesh Synthetic Scaffold Patch Graft: A Comparison of Techniques With a Minimum 2-Year Follow-up for the Treatment of Irreparable Rotator Cuff Tears. Am J Sports Med. 2025. PMID: 40376923. doi:10.1177/03635465251336190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。